Skip to content

Post-operative pain score comparison between additional intravenous dexmedetomidine, local dexmedetomidine, and placebo in patient undergoing elective open inguinal hernia repair under ilioinguinal/iliohypogastric (II/IH) nerve block and tumescent anesthesia.

Post-operative pain score comparison between additional intravenous dexmedetomidine, local dexmedetomidine, and placebo in patient undergoing elective open inguinal hernia repair under ilioinguinal/iliohypogastric (II/IH) nerve block and tumescent anesthesia, A randomized triple blinded controlled trial.

Status
Unknown
Phases
Phase 4
Study type
Interventional
Source
TCTR
Registry ID
TCTR20220208002
Enrollment
105
Registered
2022-02-08
Start date
2022-03-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postoperative pain after open inguinal hernia repair dexmedetomidine, inguinal hernia repair, ilioinguinal/iliohypogastric nerve block, tumescent anesthesia, pain

Interventions

local dexmedetomidine with local bupivacaine,IV dexmedetomidine with local bupivacaine,local bupivacaine, IV placebo
Experimental Drug,Experimental Drug,Experimental Drug
DexLA,DexIV,Control

Sponsors

Navamindradhiraj University Research Fund
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: An adult patients age 18 - 75 years uncomplicated inguinal hernia fully inform consent ASA classification I-III Non pregnant woman Non immunocompromised disease hosts including HIV, taking immunosuppressive drug, has ascites, morbid obesity

Exclusion criteria

Exclusion criteria: Emergency operation Subject cannot communicate with outcome assessor such as deafness, mental problem. Subject who is in bed ridden status. Subject who have preexisting chronic pain or daily consumption greater than 20 mg of oral morphine equivalent Subject who have either baseline heart rate less than 50 bpm, or atrioventricular block on 12-lead ECG Subject who have history of study drug allergy including dexmedetomidine, bupivacaine, propofol, fentanyl, tramadol, celecoxib, paracetamol and sulfa. Subject who have glomerular filtration rate less than or equal 30 mL per minute Subject who have history of gastrointestinal bleeding, coronary artery bypass graft surgery, and myocardial infarction

Design outcomes

Primary

MeasureTime frame
VAS at 6 hours postoperatively at 6 hours VAS

Secondary

MeasureTime frame
duration of surgery finish operation begin surgical incision to finish the operation,time to ambulation discharge from PACU, 3h, 6h, 12h, 24h postoperatively time ,time to home readiness at PACU admission, PACU discharge, 3h, 6h, 12h, 24h postoperatively modified PADSS,hospital length of stay hospital discharge time admit to discharge,PACU length of stay PACU discharge time in PACU,rate of conversion to general anesthesia intraoperative convert to general anesthesia,IV opioid consumption intraoperative, postoperative IV opioid consumption,time to first dose of postoperative opioid in first 24 hours postoperative time,, VAS at rest and on exertion at PACU admission, PACU discharge, 3rd hour, 6th hour, 12th hour, 24th hour VAS,intraoperative hypotension intraoperative blood pressure,intraoperative bradycardia intraoperative HR,femoral nerve palsy first 24 hours postoperatively manual muscle test,urinary retention first 24 hours postoperatively on foley catherter,nausea/vomiting at PACU, 0-6h, 6-12h, 12-24h postoperative nausea/vomiting,pruritus at PACU, 0-6h, 6-12h, 12-24h postoperative pruritus,hematoma at PACU, 0-6h, 6-12h, 12-24h postoperative hematoma

Countries

Thailand

Contacts

Public ContactPruchwilai Nuchpramool

Vajira hospital, Navamindradhiraj university

pruchwilai@nmu.ac.th0909699251

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026